Table 3.
Treatmenta | P-value | |||||||
---|---|---|---|---|---|---|---|---|
Item | CON | CST | CHR | CST + CHR | SEMb | CST | CHR | CST × CHR |
BW, kg | ||||||||
Initialc | 219 | 220 | 220 | 220 | 0.39 | 0.13 | 0.86 | 0.04 |
Day 14 | 230 | 234 | 230 | 233 | 1.43 | 0.04 | 0.99 | 0.73 |
Day 28 | 246 | 250 | 247 | 249 | 1.79 | 0.06 | 0.87 | 0.48 |
Day 56 | 287 | 298 | 291 | 293 | 2.67 | 0.02 | 0.95 | 0.16 |
ADG, kg | ||||||||
Initial to day 14 | 0.78 | 0.95 | 0.77 | 1.01 | 0.10 | 0.04 | 0.85 | 0.69 |
Days 14–28 | 1.12 | 1.20 | 1.16 | 1.12 | 0.11 | 0.84 | 0.86 | 0.62 |
Days 28–56 | 1.47 | 1.68 | 1.57 | 1.59 | 0.06 | 0.06 | 0.95 | 0.12 |
Initial to day 56 | 1.21 | 1.37 | 1.27 | 1.31 | 0.05 | 0.04 | 0.95 | 0.26 |
DMI, kg/d | ||||||||
Days 0–14 | 3.50 | 3.75 | 3.52 | 3.80 | 0.11 | 0.02 | 0.75 | 0.87 |
Days 14–28 | 5.13 | 5.55 | 5.13 | 5.50 | 0.17 | 0.02 | 0.86 | 0.90 |
Days 28–56 | 6.61 | 7.12 | 6.80 | 7.08 | 0.16 | 0.03 | 0.55 | 0.41 |
Days 0–56 | 5.46 | 5.88 | 5.58 | 5.86 | 0.13 | 0.01 | 0.70 | 0.60 |
G:F, kg | ||||||||
Days 0–14 | 0.2241 | 0.2551 | 0.2183 | 0.2681 | 0.0230 | 0.08 | 0.89 | 0.70 |
Days 14–28 | 0.2082 | 0.2098 | 0.2209 | 0.1833 | 0.0192 | 0.35 | 0.72 | 0.32 |
Days 28–56 | 0.2253 | 0.2367 | 0.2291 | 0.2250 | 0.0066 | 0.56 | 0.58 | 0.23 |
Days 0–56 | 0.2223 | 0.2337 | 0.2274 | 0.2245 | 0.0058 | 0.45 | 0.74 | 0.22 |
aCON = placebo control; CST = 13 g per animal daily DM inclusion of Bacillus subtilis PB6 (CLOSTAT, Kemin Industries, Des Moines, IA); CHR = 450 ppb DM chromium propionate (KemTRACE Chromium, Kemin Industries); CST + CHR = 13 g per animal daily DM inclusion of Bacillus subtilis PB6 + 450 ppb DM chromium propionate.
bStandard error of least square mean.
cInitial = average of day −1 and day 0 BW.